Establishment and characterization of DB-1: a leptin receptor-deficient murine macrophage cell line
- 265 Downloads
Metabolic and immune mediators activate many of the same signal transduction pathways. Therefore, molecules that regulate metabolism often affect immune responses. Leptin is an adipokine that exemplifies this interplay. Leptin is the body’s major nutritional status sensor, but it also plays a key role in immune system regulation. To provide an in vitro tool to investigate the link between leptin and innate immunity, we immortalized and characterized a leptin receptor-deficient macrophage cell line, DB-1. The cell line was created using bone marrow cells from leptin receptor-deficient mice. Bone marrow cells were differentiated into macrophages by culturing them with recombinant mouse macrophage colony stimulating factor, and passaged when confluent for 6 months. The cells spontaneously immortalized at approximately passage 20. Cells were cloned twice by limiting dilution cloning prior to characterization. The macrophage cell line is diploid and grows at a linear rate for 4–5 days before reaching the growth plateau. The cells are MAC-2 and F4/80 positive and have phagocytic activity similar to primary macrophages from wild-type and leptin receptor-deficient mice. DB-1 cells were responsive to stimulation with interferon-γ as measured by increase in Nos2 transcript levels. In addition, DB-1 macrophages are not responsive to the chemotactic signaling of adipocyte conditioned media nor leptin when compared to primary WT macrophages. We believe that DB-1 cells provide a dependable tool to study the role of leptin or the leptin receptor in obesity-associated inflammation and immune system dysregulation.
KeywordsMacrophages Leptin receptor Immortal cell line
This project has been supported by the American Heart Association Grant 0950036G, NIH Grants AI088070, RR17686, RR17708, NASA grant NNX08BA91G and The Kansas State Agricultural Experiment Station. This is Kansas Agricultural Experiment Station Publication #11-255-J.
- Armstrong JW, Nelson KA, Simske SJ, Luttges MW, Iandolo JJ, Chapes SK (1993) Skeletal unloading causes organ-specific changes in immune cell responses. J Appl Physiol 75:2734–2739Google Scholar
- Chan J, Leenen PJ, Bertoncello I, Nishikawa SI, Hamilton JA (1998) Macrophage lineage cells in inflammation: characterization by colony-stimulating factor-1 (CSF-1) receptor (c-Fms), ER-MP58, and ER-MP20 (Ly-6C) expression. Blood 92:1423–1431Google Scholar
- Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP (1996) Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84:491–495CrossRefGoogle Scholar
- Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292–295Google Scholar
- Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, Bulkley GB, Bao C, Noble PW, Lane MD, Diehl AM (1998) Leptin regulates proinflammatory immune responses. FASEB J 12:57–65Google Scholar
- Metcalf D, Merchav S, Wagemaker G (1982) Commitment of GM-CSF or M-CSF of bipotential GM progenitor cells to granulocyte or macrophage formation. In: Baum SJ, Ledley GD, Thierfelder S (eds) Experimental hematology today. Karger, BaselGoogle Scholar
- Schuler MF, Jefferson LS, Gorodecki J, Glaser R, Dietz J, Lipton A (1977) Selective growth of transformed cell lines by rat liver perfusate. Cancer Res 37:1662–1665Google Scholar
- Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Wool EA, Monroe CA, Tepper RI (1995) Identification and expression cloning of a leptin receptor, OB-R. Cell 83:1263–1271CrossRefGoogle Scholar